<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02982928</url>
  </required_header>
  <id_info>
    <org_study_id>IRB15-00471</org_study_id>
    <nct_id>NCT02982928</nct_id>
  </id_info>
  <brief_title>Tylenol Levels in Bariatric Patients</brief_title>
  <official_title>Acetaminophen Pharmacokinetics in Bariatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to measure and evaluate the pharmacokinetic profiling of
      acetaminophen in the young obese patient population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a descriptive study carried out by study staff from the anesthesiology
      department. The patient population will include obese patients scheduled for robot-assisted
      or laparoscopic bariatric surgery. There will be no change in our usual anesthetic care for
      these patients. Volume of distribution and elimination half-life of acetaminophen in serum
      samples are the primary measurements of the study. If detected, a significant reduction in
      opioid requirements may lead to improved patient satisfaction and decreased opiate side
      effects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intra- and Post-operative Serum Concentrations</measure>
    <time_frame>15-20 minutes; 30-40 minutes; 50-70 minutes; 80-100 minutes; 2 Hours, 4 Hours; 8 Hours; and 12-Hours Post-IV acetaminophen administration</time_frame>
    <description>To determine whether adequate serum concentration of acetaminophen is achieved.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Therapeutic Effect</measure>
    <time_frame>15-20 minutes; 30-40 minutes; 50-70 minutes; 80-100 minutes; 2 Hours, 4 Hours; 8 Hours; and 12-Hours Post-IV acetaminophen administration</time_frame>
    <description>To determine duration of therapeutic effect based on serum concentration of acetaminophen.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Establish Loading Doses for Obese Patients</measure>
    <time_frame>15-20 minutes; 30-40 minutes; 50-70 minutes; 80-100 minutes; 2 Hours, 4 Hours; 8 Hours; and 12-Hours Post-IV acetaminophen administration</time_frame>
    <description>To determine loading dose for obese patients.</description>
  </other_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of 30 patients presenting to the OR for robotic assisted
        or laparoscopic bariatric surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 12, but younger than 21 years of age undergoing robotic assisted
             or laparoscopic bariatric surgery

          -  American Society of Anesthesiologists Physical Status Classification System (ASA) I,
             II or III

          -  Parent/guardian willing and able to give consent

          -  Patient willing to give assent, or consent

          -  Patients that are otherwise healthy at the discretion of the study staff

          -  Patients with BMI &gt;95th percentile

        Exclusion Criteria:

          -  Patients with severe right heart failure or severe asthma

          -  Patients with deficient hepatic function that can affect drug metabolism

          -  Systemic steroid use within the last 3 months

          -  Patients who have taken acetaminophen containing medications within 24 hours of
             surgery date

          -  Patients younger than 12, but older than 21 years of age undergoing robotic assisted
             or laparoscopic bariatric surgery

          -  Patients having other procedures in addition to robotic assisted or laparoscopic
             bariatric surgery

          -  American Society of Anesthesiologists Physical Status Classification System (ASA) IV
             and above

          -  Females testing positive for pregnancy

          -  Parent/guardian not willing and able to give assent, or consent

          -  Patient not willing to give assent, or consent

          -  Patients with BMI &lt; 95th percentile
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahsan Syed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Dellinger, RN</last_name>
    <phone>(614) 722-2997</phone>
    <email>Heather.Dellinger@nationwidechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Rice, RN, BSN</last_name>
    <phone>(614) 355-3142</phone>
    <email>Julie.Rice@NationwideChildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahsan Syed, MD</last_name>
      <phone>614-722-4200</phone>
      <email>Ahsan.Syed@NationwideChildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Heather Dellinger, RN</last_name>
      <phone>(614) 722-2997</phone>
      <email>Heather.Dellinger@NationwideChildrens.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ziemann-Gimmel P, Hensel P, Koppman J, Marema R. Multimodal analgesia reduces narcotic requirements and antiemetic rescue medication in laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2013 Nov-Dec;9(6):975-80. doi: 10.1016/j.soard.2013.02.003. Epub 2013 Feb 13.</citation>
    <PMID>23499469</PMID>
  </reference>
  <reference>
    <citation>Saurabh S, Smith JK, Pedersen M, Jose P, Nau P, Samuel I. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015 Mar-Apr;11(2):424-30. doi: 10.1016/j.soard.2014.09.017. Epub 2014 Sep 30.</citation>
    <PMID>25614351</PMID>
  </reference>
  <reference>
    <citation>Abernethy DR, Divoll M, Greenblatt DJ, Ameer B. Obesity, sex, and acetaminophen disposition. Clin Pharmacol Ther. 1982 Jun;31(6):783-90.</citation>
    <PMID>7075126</PMID>
  </reference>
  <reference>
    <citation>Lee WH, Kramer WG, Granville GE. The effect of obesity on acetaminophen pharmacokinetics in man. J Clin Pharmacol. 1981 Jul;21(7):284-7.</citation>
    <PMID>7263926</PMID>
  </reference>
  <reference>
    <citation>Birmingham PK, Tobin MJ, Henthorn TK, Fisher DM, Berkelhamer MC, Smith FA, Fanta KB, Cot√© CJ. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology. 1997 Aug;87(2):244-52.</citation>
    <PMID>9286887</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>December 9, 2017</last_update_submitted>
  <last_update_submitted_qc>December 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Ahsan Syed</investigator_full_name>
    <investigator_title>Attending Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Bariatrics</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>robot-assisted or laparoscopic bariatric surgery</keyword>
  <keyword>Pharmacokinetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

